← Back to Search

Mobile Cognitive Behavioral Therapy App for Anxiety and Depression

N/A
Waitlist Available
Led By Jennifer Bress, Ph.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention]
Awards & highlights

Study Summary

This trial aims to compare two mobile CBT programs for anxiety/depression. Participants use Maya app 2 days/wk, 20 min/day. Assessments include questionnaires & optional MRI/EEG. Investigators think personalized program can be just as effective.

Who is the study for?
This trial is for young adults aged 18-25 with anxiety, depression, or bipolar disorder (currently in a depressive episode), who haven't started new psychotherapy or changed medication doses in the last 12 weeks. It's not for those with psychotic disorders, current manic episodes, or immediate suicide risk.Check my eligibility
What is being tested?
The study compares two mobile apps delivering cognitive behavioral therapy: a standard version and a personalized one that introduces skills faster. Participants will use an app twice weekly for six weeks and undergo assessments including questionnaires and optional brain scans.See study design
What are the potential side effects?
Since this trial involves non-invasive therapy through an app, there are no direct physical side effects like you'd expect from medication. However, discussing mental health can sometimes cause emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention]
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety symptoms from pre-intervention to post-intervention as measured by the HAM-A.
Change in depressive symptoms from pre-intervention to post-intervention as measured by HAM-D.
Secondary outcome measures
Anxious arousal from pre-intervention to post-intervention as measured by DASS.
Bipolar symptoms from pre-intervention to post-intervention as measured by ISS.
Change in Negative affect from pre-intervention to post-intervention as measured by PANAS
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PersonalizedExperimental Treatment1 Intervention
Participants receive the personalized Maya app intervention for 6 weeks
Group II: General Non-PersonalizedActive Control1 Intervention
Participants receive the general MAYA app intervention for 6 weeks

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,428 Total Patients Enrolled
4 Trials studying Bipolar Disorder
543 Patients Enrolled for Bipolar Disorder
Children's Health FundUNKNOWN
Jennifer Bress, Ph.D.Principal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
10 Total Patients Enrolled

Media Library

General MAYA Mobile App Clinical Trial Eligibility Overview. Trial Name: NCT05699525 — N/A
Bipolar Disorder Research Study Groups: Personalized, General Non-Personalized
Bipolar Disorder Clinical Trial 2023: General MAYA Mobile App Highlights & Side Effects. Trial Name: NCT05699525 — N/A
General MAYA Mobile App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05699525 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age eligibility for enrollment in this research limited to individuals 55 years or older?

"This medical trial is recruiting applicants aged 18 to 25. People younger than the specified age range can opt for one of 457 trials, while those over 65 are eligible for 1557 different studies."

Answered by AI

Is there any opportunity for candidates to join this clinical trial?

"According to clinicaltrials.gov, the study is no longer recruiting participants; though initially posted on January 1st 2023 and last updated on the 17th of that month, it has now closed its applications. Fortunately for those seeking treatment options, there are currently 2193 other studies actively enrolling patients."

Answered by AI

Who has the opportunity to participate in this clinical investigation?

"This research seeks to recruit 100 individuals aged between 18 and 25 with a primary diagnosis of an anxiety, depressive, or bipolar disorder (ADIS Clinical Severity Rating at 4+). Those experiencing bipolar disorder must be in the midst of a depressive episode."

Answered by AI

What are the goals of this clinical experiment?

"Over a 6-week period, this trial endeavours to assess changes in depressive symptoms as gauged by the Hamilton Rating Scale for Depression (HAM-D). Additionally, it will measure shifts in anhedonia through the Temporal Experience of Pleasure Scale (TEPS) and rumination using the Ruminative Response Scale (RRS). Scores on these scales range from 0 to 76; 18 to 108; and 22 to 88 respectively."

Answered by AI

Who else is applying?

What site did they apply to?
Weill Cornell Medical College
What portion of applicants met pre-screening criteria?
Met criteria
~67 spots leftby Jan 2025